Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system

3,4-Methylenedioxymethamphetamine (MDMA) is currently being investigated as an adjunctive treatment to therapy for posttraumatic stress and other anxiety related disorders in clinical trials. Within the next few years MDMA-assisted therapy is projected for approval by regulatory authorities. MDMA’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Makunts, Tigran, Dahill, Diane, Jerome, Lisa, de Boer, Alberdina, Abagyan, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233020/
https://www.ncbi.nlm.nih.gov/pubmed/37275981
http://dx.doi.org/10.3389/fpsyt.2023.1149766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233020/
https://www.ncbi.nlm.nih.gov/pubmed/37275981
http://dx.doi.org/10.3389/fpsyt.2023.1149766

Ejemplares similares